Immunotherapy and Triple Negative Breast Cancer - Mayo Clinic

A promising new study from Mayo Clinic, in conjunction with Caris Life Sciences, points to immunotherapy as a possible treatment option for patients with the difficult-to-treat triple negative breast cancer mutation. The study was presented this week at the 50th annual meeting of the American Society of Clinical Oncology in Chicago.

To learn more about breast cancer care at Mayo Clinic, visit: https://mayocl.in/2v60NoX

"This study may change our ability to treat triple negative breast cancer patients," says Barbara Pockaj, M.D., lead investigator of the study and Mayo Clinic surgeon. "We may have signs that these patients can be treated with immunotherapy. We don't have a lot of options for these patients and this would really expand our options."

Видео Immunotherapy and Triple Negative Breast Cancer - Mayo Clinic канала Mayo Clinic